Online Prescription

Weight Loss Solutions

Get Healthy!

Empower Yourself!

Semaglutide and Tirzepatide available in 4,8, and 12 week packages.

Semaglutide and Tirzepatide are also known by their brand names Ozempic, Wegovy , Mounaro, or Zepbound. They’re in a class of medications called GLP-1’S and GLP-1/GIPs. They are effective at regulating blood sugar levels, curbing appetite, and ultimately losing weight!

* Your infinity Health does not accept health insurance

Descriptive Alt Text

Accessible Care At Anytime

Infinity Health offers quick, affordable, and quality care at your fingertips!

$299 a month for medication and visits

$399 a month for medication and visits

Verified, Highly Rated & Our Customers Love Us

10%- 20% Weight Loss with Semaglutide

GLP-1 medications like Semaglutide and Tirzepatide can assist in weight loss, better fat metabolism, and glucose control. Appetite control is also an effect of these medications. With better weight management, you may also see an improvement in energy, overall mood, and wellness.

Financing Available

Buy now, pay later with no late fees or surprises

What Our Customers Say?

Feedback from these happy customers helps us in reaching the heights

Semaglutide vs. Tirzepatide: Which Is Best for You?

$299 a month

Semaglutide, known by brand names like Ozempic and Wegovy, is a GLP-I (glucagon-like peptide-I) receptor agonist. Originally developed to manage type 2 diabetes, it has been approved for weight management due to its impressive efficacy in romotin wei ht loss.

What is Semaglutide?

How Do They Work?

Semaglutide mimics the action of the GLP-I hormone, which regulates appetite and food intake. By slowing gastric emptying and enhancing feelings of fullness, it helps reduce overall caloric intake.

Mechanism of Action ?

Mimics GLP-I hormone action.

Slows gastric emptying.

Enhances feelings of fullness

$399 a month

What is Tirzepatide?

Tirzepatide, marketed under the brand nam Mounjaro, is a dual GIP (glucose-dependen insulinotropic polypeptide) and GLP-I recepto agonist. This newer medication was also initiall developed for diabetes management and has show significant potential for weight reduction.

How Do They Work?

Tirzepatide targets both GIP and GLP-I receptors, enhancing insulin secretion, slowing gastric emptying, and reducing appetite. This dual action offers a unique approach compared to single-action treatments like Sema lutide.

Mechanism of Action ?

Targets both GIP and GLP-I receptors.

Enhances insulin secretion.

Slows gastric emptying.

Reduces appetite through a dual mechanism.